1. Home
  2. LAES vs ATYR Comparison

LAES vs ATYR Comparison

Compare LAES & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$2.30

Market Cap

675.0M

Sector

Technology

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

N/A

Current Price

$0.31

Market Cap

49.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAES
ATYR
Founded
2022
2005
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.0M
49.2M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
LAES
ATYR
Price
$2.30
$0.31
Analyst Decision
Buy
Hold
Analyst Count
1
9
Target Price
★ $4.00
$3.67
AVG Volume (30 Days)
★ 4.3M
2.6M
Earning Date
03-31-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.98
EPS
★ N/A
N/A
Revenue
N/A
★ $190,000.00
Revenue This Year
$93.36
N/A
Revenue Next Year
$43.06
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.99
$0.28
52 Week High
$8.71
$1.12

Technical Indicators

Market Signals
Indicator
LAES
ATYR
Relative Strength Index (RSI) 43.47 27.82
Support Level $2.22 N/A
Resistance Level $2.61 $0.59
Average True Range (ATR) 0.09 0.03
MACD 0.01 -0.01
Stochastic Oscillator 35.19 16.37

Price Performance

Historical Comparison
LAES
ATYR

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: